de Mello D, Menezes J, de Oliveira A, Cristovao M, Kimura E, Fuziwara C
Arch Endocrinol Metab. 2025; 68(Spec Issue):e240073.
PMID: 39876973
PMC: 11771757.
DOI: 10.20945/2359-4292-2024-0073.
Rudalska R, Harbig J, Forster M, Woelffing P, Esposito A, Kudolo M
Nat Cancer. 2025; 6(2):259-277.
PMID: 39820127
PMC: 11864979.
DOI: 10.1038/s43018-024-00899-7.
Brodeur M, Dopeso H, Zhu Y, Longhini A, Gazzo A, Sun S
Sci Adv. 2024; 10(49):eadk4851.
PMID: 39630912
PMC: 11616711.
DOI: 10.1126/sciadv.adk4851.
Kim J, Tadros B, Liang Y, Kim Y, Lasagna-Reeves C, Sonn J
Nat Neurosci. 2024; 27(12):2417-2429.
PMID: 39528671
PMC: 11614740.
DOI: 10.1038/s41593-024-01777-2.
Yang J, Zhu X, Wang F, Chen Z, Zhang Y, Chen J
CNS Neurosci Ther. 2024; 30(10):e70075.
PMID: 39390804
PMC: 11467166.
DOI: 10.1111/cns.70075.
The small inhibitor WM-1119 effectively targets KAT6A-rearranged AML, but not KMT2A-rearranged AML, despite shared KAT6 genetic dependency.
Sheridan M, Maqbool M, Largeot A, Clayfield L, Xu J, Moncaut N
J Hematol Oncol. 2024; 17(1):91.
PMID: 39380002
PMC: 11462755.
DOI: 10.1186/s13045-024-01610-0.
Enhancer reprogramming underlies therapeutic utility of a SMARCA2 degrader in SMARCA4 mutant cancer.
Kotagiri S, Blazanin N, Xi Y, Han Y, Qudratullah M, Liang X
Cell Chem Biol. 2024; 31(12):2069-2084.e9.
PMID: 39378885
PMC: 11663135.
DOI: 10.1016/j.chembiol.2024.09.004.
Creation of de novo cryptic splicing for ALS and FTD precision medicine.
Wilkins O, Chien M, Wlaschin J, Barattucci S, Harley P, Mattedi F
Science. 2024; 386(6717):61-69.
PMID: 39361759
PMC: 7616720.
DOI: 10.1126/science.adk2539.
Therapeutic modulation of ROCK overcomes metabolic adaptation of cancer cells to OXPHOS inhibition and drives synergistic anti-tumor activity.
Blazanin N, Liang X, Mahmud I, Kim E, Martinez S, Tan L
bioRxiv. 2024; .
PMID: 39345502
PMC: 11429714.
DOI: 10.1101/2024.09.16.613317.
Acidity suppresses CD8 + T-cell function by perturbing IL-2, mTORC1, and c-Myc signaling.
Vuillefroy de Silly R, Pericou L, Seijo B, Crespo I, Irving M
EMBO J. 2024; 43(21):4922-4953.
PMID: 39284912
PMC: 11535206.
DOI: 10.1038/s44318-024-00235-w.
The BCL11A transcription factor stimulates the enzymatic activities of the OGG1 DNA glycosylase.
Petrachkova T, Soldatkina O, Leduy L, Nepveu A
Biol Chem. 2024; 405(11-12):711-726.
PMID: 39272221
PMC: 11712033.
DOI: 10.1515/hsz-2024-0088.
Bcl-xL is translocated to the nucleus via CtBP2 to epigenetically promote metastasis.
Zhang T, Li S, Tan Y, Chen X, Zhang C, Chen Z
Cancer Lett. 2024; 604:217240.
PMID: 39265800
PMC: 11471366.
DOI: 10.1016/j.canlet.2024.217240.
Identifying a gene signature of metastatic potential by linking pre-metastatic state to ultimate metastatic fate.
Handler J, Li Z, Dveirin R, Fang W, Goodarzi H, Fertig E
bioRxiv. 2024; .
PMID: 39185156
PMC: 11343111.
DOI: 10.1101/2024.08.14.607813.
Association with TFIIIC limits MYCN localisation in hubs of active promoters and chromatin accumulation of non-phosphorylated RNA polymerase II.
Vidal R, Leen E, Herold S, Muller M, Fleischhauer D, Schulein-Volk C
Elife. 2024; 13.
PMID: 39177021
PMC: 11343564.
DOI: 10.7554/eLife.94407.
IER3IP1-mutations cause microcephaly by selective inhibition of ER-Golgi transport.
Anitei M, Bruno F, Valkova C, Dau T, Cirri E, Mestres I
Cell Mol Life Sci. 2024; 81(1):334.
PMID: 39115595
PMC: 11335259.
DOI: 10.1007/s00018-024-05386-x.
Suppression of toxic transgene expression by optimized artificial miRNAs increases AAV vector yields in HEK-293 cells.
Blahetek G, Mayer C, Zuber J, Lenter M, Strobel B
Mol Ther Methods Clin Dev. 2024; 32(3):101280.
PMID: 39015407
PMC: 11250862.
DOI: 10.1016/j.omtm.2024.101280.
Mitoferrin2 is a synthetic lethal target for chromosome 8p deleted cancers.
Krieg S, Rohde T, Rausch T, Butthof L, Wendler-Link L, Eckert C
Genome Med. 2024; 16(1):83.
PMID: 38886830
PMC: 11181659.
DOI: 10.1186/s13073-024-01357-w.
Targeting MYC effector functions in pancreatic cancer by inhibiting the ATPase RUVBL1/2.
Vogt M, Dudvarski Stankovic N, Cruz Garcia Y, Hofstetter J, Schneider K, Kuybu F
Gut. 2024; 73(9):1509-1528.
PMID: 38821858
PMC: 11347226.
DOI: 10.1136/gutjnl-2023-331519.
Design of antiviral AGO2-dependent short hairpin RNAs.
Bie Y, Zhang J, Chen J, Zhang Y, Huang M, Zhang L
Virol Sin. 2024; 39(4):645-654.
PMID: 38734183
PMC: 11401469.
DOI: 10.1016/j.virs.2024.05.001.
Induction of antiviral interferon-stimulated genes by neuronal STING promotes the resolution of pain in mice.
Defaye M, Bradaia A, Abdullah N, Agosti F, Iftinca M, Delanne-Cumenal M
J Clin Invest. 2024; 134(9).
PMID: 38690737
PMC: 11060736.
DOI: 10.1172/JCI176474.